Evidence map›Paper›PMID 24585897›Full record

ArticleThe Journal of infectious diseases2014

Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.

Carey L Shive, Joseph C Mudd, Nicholas T Funderburg, Scott F Sieg, Benjamin Kyi, Doug A Bazdar, Davide Mangioni, Andrea Gori, Jeffrey M Jacobson, Ari D Brooks and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Inflammatory Phenotypes Predict Changes in Arterial Stiffness Following Antiretroviral Therapy Initiation.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Carey L ShiveCenter for AIDS Research, Case Western Reserve University.
Joseph C MuddCenter for AIDS Research, Case Western Reserve University.
Nicholas T FunderburgCenter for AIDS Research, Case Western Reserve University School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, Ohio.
Scott F SiegCenter for AIDS Research, Case Western Reserve University.
Benjamin KyiCenter for AIDS Research, Case Western Reserve University.
Doug A BazdarCenter for AIDS Research, Case Western Reserve University.
Davide MangioniDivision of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Andrea GoriDivision of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Jeffrey M JacobsonDivision of Infectious Diseases and HIV Medicine, Drexel University College of Medicine.
Ari D BrooksEndocrine and Oncologic Surgery, Pennsylvania Hospital, Philadelphia, Pennsylvania.
Jeffrey HardacreUniversity Hospitals/Case Medical Center, Cleveland.
John AmmoriUniversity Hospitals/Case Medical Center, Cleveland.
Jacob D EstesAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, SAIC-Frederick, Maryland.
Timothy W SchackerUniversity of Minnesota, Minneapolis.
Benigno RodriguezCenter for AIDS Research, Case Western Reserve University.
Michael M LedermanCenter for AIDS Research, Case Western Reserve University.
Case Western Reserve University · USUniversity Hospitals Case Medical Center · USUniversity of Milano-Bicocca · ITDrexel University · USFrederick National Laboratory for Cancer Research · USPennsylvania Hospital · USThe Ohio State University · USUniversity of Minnesota System · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
Specimen Acquisition and Distribution CoreP01AI076174 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEDERMAN, MICHAEL MARCEL · 2008 to 2012
$10.9M
Immunology Training Program-PredoctoralT32AI089474 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI COBB, BRIAN A · 2010 to 2025
$3.4M
Tissue factor expression in HIV disease - Implications for cardiovascular riskR00HL108743 · NHLBI · OHIO STATE UNIVERSITY · PI FUNDERBURG, NICHOLAS T. · 2014 to 2016
$747k
NHLBI NIH HHS R00 HL108743NIAID NIH HHS AI 076174NIAID NIH HHS AI 36219NIAID NIH HHS AI-68636NIAID NIH HHS P01 AI076174NIAID NIH HHS P30 AI036219NIAID NIH HHS T32 AI089474NIAID NIH HHS U01 AI068636NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI106701
6 · The paper itself

Abstract

backgroundSystemic inflammation has been linked to a failure to normalize CD4(+) T-cell numbers in treated human immunodeficiency virus (HIV) infection. Although inflammatory cytokines such as interleukin 6 (IL-6) are predictors of disease progression in treated HIV infection, it is not clear how or whether inflammatory mediators contribute to immune restoration failure.

methodsWe examined the in vitro effects of IL-6 and interleukin 1β (IL-1β) on peripheral blood T-cell cycling and CD127 surface expression.

resultsThe proinflammatory cytokine IL-1β induces cell cycling and turnover of memory CD4(+) T cells, and IL-6 can induce low-level cycling of naive T cells. Both IL-1β and IL-6 can decrease T-cell surface expression and RNA levels of CD127, the interleukin 7 receptor α chain (IL-7Rα). Preexposure of healthy peripheral blood mononuclear cells (PBMCs) to IL-6 or IL-1β attenuates IL-7-induced Stat5 phosphorylation and induction of the prosurvival factor Bcl-2 and the gut homing integrin α4β7. We found elevated expression of IL-1β in the lymphoid tissues of patients with HIV infection that did not normalize with antiretroviral therapy.

conclusionsInduction of CD4(+) T-cell turnover and diminished T-cell responsiveness to IL-7 by IL-1β and IL-6 exposure may contribute to the lack of CD4(+) T-cell reconstitution in treated HIV-infected subjects.

Indexed as

Antiretroviral Therapy, Highly ActiveCD4-Positive T-LymphocytesCell CycleCells, CulturedHIV-1HIV InfectionsHumansInflammationInterleukin-1betaInterleukin-6Interleukin-7Interleukin-7 Receptor alpha SubunitLeukocytes, MononuclearReceptors, Interleukin-7Interleukin-1betaInterleukin-6Interleukin-7interleukin-7 receptor, alpha chainInterleukin-7 Receptor alpha SubunitReceptors, Interleukin-7HIVimmune failureinflammationinterleukin 1 betainterleukin 6interleukin 7

Identifiers

PMID24585897
PMCPMC4172041
OpenAlexW2105646872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.